Skip to main content
Log in

Primary aldosteronism in 2011

Towards a better understanding of causation and consequences

  • Year in Review
  • Published:

From Nature Reviews Endocrinology

View current issue Sign up to alerts

With primary aldosteronism now widely acknowledged as common and associated with both hypertension-related and non-hypertension-related pathology, research interest into its causes and consequences continues to grow. In 2011, major breakthroughs occurred in understanding the role and nature of underlying genetic disturbances and elucidating the pathophysiology of its cardiovascular sequelae.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1: Cellular and functional zones of steroid synthesis in the adrenal cortex.

References

  1. Sutherland, D. J., Ruse, J. L. & Laidlaw, J. C. Hypertension, increased aldosterone secretion and low plasma renin activity relieved by dexamethasone. Can. Med. Assoc. J. 95, 1109–1119 (1966).

    CAS  PubMed  PubMed Central  Google Scholar 

  2. Lifton, R. P. et al. Hereditary hypertension caused by chimaeric gene duplications and ectopic expression of aldosterone synthase. Nat. Genet. 2, 66–74 (1992).

    Article  CAS  Google Scholar 

  3. Stowasser, M., Pimenta, E. & Gordon, R. D. Familial or genetic primary aldosteronism and Gordon syndrome. Endocrinol. Metab. Clin. North Am. 40, 343–368, viii (2011).

    Article  CAS  PubMed  Google Scholar 

  4. Mulatero, P. et al. Prevalence and characteristics of familial hyperaldosteronism: the PATOGEN study (Primary Aldosteronism in TOrino-GENetic forms). Hypertension 58, 797–803 (2011).

    Article  CAS  PubMed  Google Scholar 

  5. Choi, M. et al. K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension. Science 331, 768–772 (2011).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Geller, D. S. et al. A novel form of human mendelian hypertension featuring nonglucocorticoid-remediable aldosteronism. J. Clin. Endocrinol. Metab. 93, 3117–3123 (2008).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Gordon, R. D., Hamlet, S. M., Tunny, T. J. & Klemm, S. A. Aldosterone-producing adenomas responsive to angiotensin pose problems in diagnosis. Clin. Exp. Pharmacol. Physiol. 14, 175–179 (1987).

    Article  CAS  PubMed  Google Scholar 

  8. Tunny, T. J., Gordon, R. D., Klemm, S. A. & Cohn, D. Histological and biochemical distinctiveness of atypical aldosterone-producing adenomas responsive to upright posture and angiotensin. Clin. Endocrinol. (Oxf.) 34, 363–369 (1991).

    Article  CAS  Google Scholar 

  9. Wu, V. C. et al. Endothelial progenitor cells in primary aldosteronism: a biomarker of severity for aldosterone vasculopathy and prognosis. J. Clin. Endocrinol. Metab. 96, 3175–3183 (2011).

    Article  CAS  PubMed  Google Scholar 

  10. Pimenta, E. et al. Cardiac dimensions are largely determined by dietary salt in patients with primary aldosteronism: results of a case–control study. J. Clin. Endocrinol. Metab. 96, 2813–2820 (2011).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Stowasser, M. Towards a better understanding of causation and consequences. Nat Rev Endocrinol 8, 70–72 (2012). https://doi.org/10.1038/nrendo.2011.223

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrendo.2011.223

  • Springer Nature Limited

This article is cited by

Navigation